Literature DB >> 464392

Effect of portasystemic shunt on hypersplenism: clinical study in 129 patients with cirrhosis.

M Puttini, A Marni, F Montes, L Belli.   

Abstract

The effect of portasystemic shunts on hypersplenism has been evaluated in 129 patients who were operated upon. Correction of hypersplenism was obtained in 79 per cent of patients with shunting procedures without splenectomy and 90 per cent of those with splenectomy. The improvement was significant and lasting. These results confirm the beneficial effect of splenic decompression on hypersplenism after simple portasystemic shunt. On the basis of these data, we feel that a difficult splenectomy can also be avoided in patients who have cirrhosis with striking hypersplenism.

Entities:  

Mesh:

Year:  1979        PMID: 464392

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  10 in total

1.  Reversal of hypersplenism following orthotopic liver transplantation.

Authors:  K Yanaga; A G Tzakis; M Shimada; W E Campbell; J W Marsh; A C Stieber; L Makowka; S Todo; R D Gordon; S Iwatsuki
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

2.  β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.

Authors:  Ujjal Poddar; Upender Shava; Surender Kumar Yachha; Jaya Agarwal; Sheo Kumar; Sanjay S Baijal; Anshu Srivastava
Journal:  Hepatol Int       Date:  2014-09-23       Impact factor: 6.047

3.  The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.

Authors:  Omar I Massoud; Nizar N Zein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-05

4.  Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.

Authors:  Z Karasu; A Gurakar; B Kerwin; S Hulagu; A Jazzar; R McFadden; B Nour; A Sebastian; F Cassidy; K Stokes; D H Van Thiel; H Wright
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

5.  Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?

Authors:  N Jabbour; A Zajko; P Orons; W Irish; J J Fung; R R Selby
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 6.  Abnormal hematological indices in cirrhosis.

Authors:  A A Qamar; N D Grace
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

7.  Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.

Authors:  Elise J Barney; Ester C Little; Richard D Gerkin; Alberto X Ramos; Jeffrey Kahn; Mark Wong; Geetha Kolli; Richard Manch
Journal:  Dig Dis Sci       Date:  2012-05-16       Impact factor: 3.199

8.  Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis.

Authors:  S P Lawrence; D C Lezotte; J D Durham; D A Kumpe; G T Everson; B M Bilir
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

9.  Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C.

Authors:  Zeki Karasu; Fatih Tekin; Galip Ersoz; Fulya Gunsar; Yucel Batur; Tankut Ilter; Ulus S Akarca
Journal:  Dig Dis Sci       Date:  2007-04-27       Impact factor: 3.487

10.  Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology.

Authors:  Masatoshi Ishigami; Yoji Ishizu; Yasuharu Onishi; Hideya Kamei; Tetsuya Kiuchi; Akihiro Itoh; Yoshiki Hirooka; Yoshiaki Katano; Hidemi Goto
Journal:  Springerplus       Date:  2013-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.